MedPath

Translation and Implementation of the Dutch VVAS Score in Clinical Practice

Not Applicable
Not yet recruiting
Conditions
Vertigo
Interventions
Diagnostic Test: Visual Vertigo Analogue Scale (VVAS)
Registration Number
NCT06017466
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

The aim of this study is to translate and introduce a cross-cultural adaptation of The Visual Vertigo Analogue Scale (VVAS). E. Dannenbaum et al developed the VVAS in order to diagnose visual vertigo (VV). VV is dizziness caused by visual stimuli such as scrolling through a computer screen or walking through crowds of people or supermarket aisles.

Detailed Description

The Visual Vertigo Analogue Scale (VVAS) was developed by E. Dannenbaum et al in 2011 to diagnose visual vertigo. It is a nine-item analogue scale in which the subjects can rate their symptoms' intensity. The symptoms can be categorized as None (0), Mild (0.1-40), Moderate (40.01-70), or Severe (70.01-100). The VVAS is already available in English and French but a Dutch version does not yet exist. In this study, we would like to translate and introduce a cross-cultural adaptation of the VVAS into Dutch for use with vestibular patients in Belgium.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • All patient with chronic vertigo (>3 years) will included
  • Interpretation of the VVAS is be possible
  • 18-75 year
Exclusion Criteria
  • Unable to read Dutch
  • Single episode of vertigo
  • > 75 year
  • Minors
  • When no interpretation of the VVAS is possible (e.g. too young, dementia)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Chronic VertigoVisual Vertigo Analogue Scale (VVAS)Chronic vertigo patients can be divided into three groups. The first pathway is episodic vertigo (caused by e.g. migraine, Ménière's disease, benign paroxysmal positional vertigo (BPPV)) progressively leading to chronic dizziness. The second pathway is initiated by a single attack of vertigo (e.g. neuritis vestibularis) with some initial recovery but later on residual symptoms. The third pathway is the presence of chronic, slowly progressive, continuous, or unchanging symptoms (e.g. bilateral vestibular failure, CNS disorders). All patient with chronic vertigo (see above) will included.
Primary Outcome Measures
NameTimeMethod
vertigo symptoms assessed by the visual analogue scale1 year

Unit of measurement: score from 1 to 10 measurement tool: VVAS questionnaire

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath